tiprankstipranks
BioAge Labs, Inc. (BIOA)
NASDAQ:BIOA
US Market

BioAge Labs, Inc. (BIOA) Financial Statements

Compare
66 Followers

BioAge Labs, Inc. Financial Overview

BioAge Labs, Inc.'s market cap is currently $165.98M. The company's EPS TTM is $; its P/E ratio is ―; BioAge Labs, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00
Operating Income$ -48.40M$ -39.97M
EBITDA$ -45.81M$ -39.38M
Net Income$ -63.85M$ -39.72M
Balance Sheet
Cash & Short-Term Investments$ 21.64M$ 27.64M
Total Assets$ 25.92M$ 28.43M
Total Debt$ 53.25M$ 2.47M
Net Debt$ 31.61M$ -25.18M
Total Liabilities$ 199.32M$ 140.99M
Stockholders' Equity$ -173.40M$ -112.56M
Cash Flow
Free Cash Flow$ -37.53M$ -36.28M
Operating Cash Flow$ -37.36M$ -36.18M
Investing Cash Flow$ -266.00K$ -103.00K
Financing Cash Flow$ 34.94M$ 2.50M
Currency in USD

BioAge Labs, Inc. Earnings and Revenue History

BioAge Labs, Inc. Debt to Assets

BioAge Labs, Inc. Cash Flow

BioAge Labs, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis